Compile Data Set for Download or QSAR
Report error Found 17 Enz. Inhib. hit(s) with all data for entry = 6291
TargetCarboxypeptidase B(Human)
Sanofi-Aventis Deutschland

US Patent
LigandPNGBDBM120796(US8710232, 33)
Affinity DataIC50: 3nMpH: 7.4 T: 2°CAssay Description:The prepared substances were tested for TAFIa inhibition using the Actichrome plasma TAFI activity kit from American Diagnostica (Pr. No. 874). This ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/14/2014
Entry Details
US Patent

TargetCarboxypeptidase B(Human)
Sanofi-Aventis Deutschland

US Patent
LigandPNGBDBM120790(US8710232, 17)
Affinity DataIC50: 11nMpH: 7.4 T: 2°CAssay Description:The prepared substances were tested for TAFIa inhibition using the Actichrome plasma TAFI activity kit from American Diagnostica (Pr. No. 874). This ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/14/2014
Entry Details
US Patent

TargetCarboxypeptidase B(Human)
Sanofi-Aventis Deutschland

US Patent
LigandPNGBDBM120788(US8710232, 15)
Affinity DataIC50: 12nMpH: 7.4 T: 2°CAssay Description:The prepared substances were tested for TAFIa inhibition using the Actichrome plasma TAFI activity kit from American Diagnostica (Pr. No. 874). This ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/14/2014
Entry Details
US Patent

TargetCarboxypeptidase B(Human)
Sanofi-Aventis Deutschland

US Patent
LigandPNGBDBM120787(US8710232, 13)
Affinity DataIC50: 12nMpH: 7.4 T: 2°CAssay Description:The prepared substances were tested for TAFIa inhibition using the Actichrome plasma TAFI activity kit from American Diagnostica (Pr. No. 874). This ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/14/2014
Entry Details
US Patent

TargetCarboxypeptidase B(Human)
Sanofi-Aventis Deutschland

US Patent
LigandPNGBDBM120786(US8710232, 12)
Affinity DataIC50: 15nMpH: 7.4 T: 2°CAssay Description:The prepared substances were tested for TAFIa inhibition using the Actichrome plasma TAFI activity kit from American Diagnostica (Pr. No. 874). This ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/14/2014
Entry Details
US Patent

TargetCarboxypeptidase B(Human)
Sanofi-Aventis Deutschland

US Patent
LigandPNGBDBM120782(US8710232, 7)
Affinity DataIC50: 16nMpH: 7.4 T: 2°CAssay Description:The prepared substances were tested for TAFIa inhibition using the Actichrome plasma TAFI activity kit from American Diagnostica (Pr. No. 874). This ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/14/2014
Entry Details
US Patent

TargetCarboxypeptidase B(Human)
Sanofi-Aventis Deutschland

US Patent
LigandPNGBDBM120791(US8710232, 18)
Affinity DataIC50: 21nMpH: 7.4 T: 2°CAssay Description:The prepared substances were tested for TAFIa inhibition using the Actichrome plasma TAFI activity kit from American Diagnostica (Pr. No. 874). This ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/14/2014
Entry Details
US Patent

TargetCarboxypeptidase B(Human)
Sanofi-Aventis Deutschland

US Patent
LigandPNGBDBM120785(US8710232, 10)
Affinity DataIC50: 23nMpH: 7.4 T: 2°CAssay Description:The prepared substances were tested for TAFIa inhibition using the Actichrome plasma TAFI activity kit from American Diagnostica (Pr. No. 874). This ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/14/2014
Entry Details
US Patent

TargetCarboxypeptidase B(Human)
Sanofi-Aventis Deutschland

US Patent
LigandPNGBDBM120781(US8710232, 1)
Affinity DataIC50: 30nMpH: 7.4 T: 2°CAssay Description:The prepared substances were tested for TAFIa inhibition using the Actichrome plasma TAFI activity kit from American Diagnostica (Pr. No. 874). This ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/14/2014
Entry Details
US Patent

TargetCarboxypeptidase B(Human)
Sanofi-Aventis Deutschland

US Patent
LigandPNGBDBM120789(US8710232, 16)
Affinity DataIC50: 38nMpH: 7.4 T: 2°CAssay Description:The prepared substances were tested for TAFIa inhibition using the Actichrome plasma TAFI activity kit from American Diagnostica (Pr. No. 874). This ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/14/2014
Entry Details
US Patent

TargetCarboxypeptidase B(Human)
Sanofi-Aventis Deutschland

US Patent
LigandPNGBDBM120797(US8710232, 37)
Affinity DataIC50: 49nMpH: 7.4 T: 2°CAssay Description:The prepared substances were tested for TAFIa inhibition using the Actichrome plasma TAFI activity kit from American Diagnostica (Pr. No. 874). This ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/14/2014
Entry Details
US Patent

TargetCarboxypeptidase B(Human)
Sanofi-Aventis Deutschland

US Patent
LigandPNGBDBM120784(US8710232, 9)
Affinity DataIC50: 439nMpH: 7.4 T: 2°CAssay Description:The prepared substances were tested for TAFIa inhibition using the Actichrome plasma TAFI activity kit from American Diagnostica (Pr. No. 874). This ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/14/2014
Entry Details
US Patent

TargetCarboxypeptidase B(Human)
Sanofi-Aventis Deutschland

US Patent
LigandPNGBDBM120795(US8710232, 31)
Affinity DataIC50: 870nMpH: 7.4 T: 2°CAssay Description:The prepared substances were tested for TAFIa inhibition using the Actichrome plasma TAFI activity kit from American Diagnostica (Pr. No. 874). This ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/14/2014
Entry Details
US Patent

TargetCarboxypeptidase B(Human)
Sanofi-Aventis Deutschland

US Patent
LigandPNGBDBM120793(US8710232, 27)
Affinity DataIC50: 1.11E+3nMpH: 7.4 T: 2°CAssay Description:The prepared substances were tested for TAFIa inhibition using the Actichrome plasma TAFI activity kit from American Diagnostica (Pr. No. 874). This ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/14/2014
Entry Details
US Patent

TargetCarboxypeptidase B(Human)
Sanofi-Aventis Deutschland

US Patent
LigandPNGBDBM120783(US8710232, 8)
Affinity DataIC50: 1.13E+3nMpH: 7.4 T: 2°CAssay Description:The prepared substances were tested for TAFIa inhibition using the Actichrome plasma TAFI activity kit from American Diagnostica (Pr. No. 874). This ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/14/2014
Entry Details
US Patent

TargetCarboxypeptidase B(Human)
Sanofi-Aventis Deutschland

US Patent
LigandPNGBDBM120794(US8710232, 28)
Affinity DataIC50: 1.44E+3nMpH: 7.4 T: 2°CAssay Description:The prepared substances were tested for TAFIa inhibition using the Actichrome plasma TAFI activity kit from American Diagnostica (Pr. No. 874). This ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/14/2014
Entry Details
US Patent

TargetCarboxypeptidase B(Human)
Sanofi-Aventis Deutschland

US Patent
LigandPNGBDBM120792(US8710232, 25)
Affinity DataIC50: 1.05E+4nMpH: 7.4 T: 2°CAssay Description:The prepared substances were tested for TAFIa inhibition using the Actichrome plasma TAFI activity kit from American Diagnostica (Pr. No. 874). This ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/14/2014
Entry Details
US Patent